New comedications added in July

The following comedications have been added to the interaction checker in July:

• Emicizumab (Antihaemorrhagics)
• Epcoritamab (Cancer Therapies)
• Inclisiran (Lipid Lowering Agents)
• Isatuximab (Cancer Therapies)
• Tildrakizumab (Immuno-suppressants)